Abstract
During the SARS-Cov-2 pandemic, patients with immune-mediated inflammatory diseases (IMIDs) were faced with two pressing questions. Firstly, as these patients often use immunosuppressants, it was not known whether they would build sufficient immunity after a SARS-CoV-2 infection or vaccination. Secondly, IMID patients were concerned that vaccination could
| Original language | English |
|---|---|
| Qualification | Doctor of Philosophy |
| Awarding Institution |
|
| Supervisors/Advisors |
|
| Award date | 5 Jun 2024 |
| Publication status | Published - 2024 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'SARS-CoV-2 vaccination: Immunity and disease activity in immune- mediated inflammatory diseases'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver